Research Article
Cytotoxic Constituents of the Bark of Hypericum roeperianum towards Multidrug-Resistant Cancer Cells
Table 1
Recorded IC50 values after 72 h incubation of drug-sensitive and MDR cancer cells lines with botanicals from the bark of Hypericum roeperianum.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(): the degree of resistance was determined as the ratio of the IC50 value in the resistant divided by the IC50 in the sensitive cell line; CEM/ADR5000, MDA-MB-231-BCRP, HCT116 (p53−/−), and U87MG.ΔEGFR were used as the corresponding resistant counterpart for CCRF-CEM, MDA-MB-231-pcDNA, HCT116 (p53+/+), and U87MG, respectively; (): the selectivity index was determined as the ratio of the IC50 value in the normal AML12 hepatocytes divided by the IC50 in HepG2 hepatocarcinoma cells; in bold: significant cytotoxic effect [7, 39, 40]; nd: not determined; HRB: crude methanol extract from the bark of Hypericum roeperianum, HRBa: portion obtained by exhaustion of HRB with ethyl acetate; HRBa1-5: fractions from HRBa; HRBb: residual fraction obtained after exhaustion of HRB with ethyl acetate. The data for doxorubicin used as positive control in similar experimental conditions are shown in Table 2. |